Bill Fleckenstein: Bulls May Find Themselves "Up To Their Neck In Alligators" Soon
You'd have to be crazy to ignore today's market risk
For a long time now, passive capital inflows have powered equities higher, especially the Magnificent 7, as a tremendous percent of every new dollar that flows into the market goes into these seven stocks.
But some of these once-bulletproof companies are now starting to struggle.
And those passive capital inflows? There are emerging signs they may be stalling, perhaps even starting to reverse.
If true, could that take asset prices down just as powerfully as it drove them higher?
To help us find out, as investors have a lot riding on the answer, we have the good fortune of speaking with investor and analyst Bill Fleckenstein of Fleckenstein Capital.
He thinks that, while the current exuberance could last for a bit longer, you’d have to be crazy to ignore the high degree of correction risk in today’s market.
For his reasons why, and how he’s positioning his assets, click here or on the image below:
REPLAY PURCHASE NOW AVAILABLE: Replay videos of yesterday’s amazing 9-hour Thoughtful Money’s conference are now available for purchase:
I’m so grateful to everyone who has made their way to Thoughtful Money, especially those of you who have kindly supported me by becoming a premium subscriber to this new Substack. It’s making an important difference in helping me afford the substantial startup costs of birthing this new venture.
Premium supporters will receive my “Adam’s Notes” summaries to interviews going forward (yes, they’re back!), plus periodic advance-viewing and/or exclusive content not made available to the public.
My Adam’s Notes for this discussion with Bill are available to them below.
If you, too, would like to become a premium subscriber to this Substack (it’s just $15/mo, less than $0.50/day), then sign up now here:
Keep reading with a 7-day free trial
Subscribe to Adam Taggart's Thoughtful Money to keep reading this post and get 7 days of free access to the full post archives.